DEF 14A
PROXY STATEMENT
- Company
- AIM ImmunoTech Inc.
- Filed
- July 17, 2001
- Period of Report
- August 24, 2001
- Accession Number
- 0000912057-01-524164
A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →